Belgium - Beta Blocking Medicine Use
Since 2014, Belgium Beta Blocking Medicine Use decreased by 1.3% year on year. In 2019, the country was ranked number 3 among other countries in Beta Blocking Medicine Use at 72.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Belgium is overtaken by Lithuania, which was number 2 at 76.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Hungary at 72.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Germany topped the ranking with 81.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 2.1% versus 2018. Turkey witnessed the best average annual growth at +5% per year, while Chile recorded the worst performance at -4.9% per year.
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 72.50 |
| 2018 | 71.70 |
| 2017 | 73.40 |
| 2016 | 75.60 |
| 2015 | 76.40 |
How does Belgium rank in Beta Blocking Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
82 | 2019 | +2.1 % | -1.6 % | View data |
| 2 |
#2
Lithuania
|
77 | 2019 | +3.4 % | +1.6 % | View data |
| 3 |
#3
Belgium
|
73 | 2019 | +1.1 % | -1.3 % | View data |
| 4 |
#4
Hungary
|
72 | 2019 | +0.3 % | +1.7 % | View data |
| 5 |
#5
Slovakia
|
67 | 2019 | +2.5 % | -1.2 % | View data |